NO20044507L - 1-oksa-3-aza-dibenzoazulener som inhibitorer av tumornekrosefaktorproduksjon og mellomprodukter for fremstilling derav - Google Patents

1-oksa-3-aza-dibenzoazulener som inhibitorer av tumornekrosefaktorproduksjon og mellomprodukter for fremstilling derav

Info

Publication number
NO20044507L
NO20044507L NO20044507A NO20044507A NO20044507L NO 20044507 L NO20044507 L NO 20044507L NO 20044507 A NO20044507 A NO 20044507A NO 20044507 A NO20044507 A NO 20044507A NO 20044507 L NO20044507 L NO 20044507L
Authority
NO
Norway
Prior art keywords
aza
oxa
intermediates
preparation
necrosis factor
Prior art date
Application number
NO20044507A
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Dijana Pesic
Iva Benko
Original Assignee
Pliva Istrazivacki Inst Doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Inst Doo filed Critical Pliva Istrazivacki Inst Doo
Publication of NO20044507L publication Critical patent/NO20044507L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår derivater av 1 -oksa-3-aza-dibenzoazulenklasse, deres farmakologisk akseptable salter og solvater, fremgangsmåter og mellomprodukter for fremstillingen derav, så vel som deres anti-inflammatoriske virkninger, spesielt hemning av tumornekrosefaktor-a- (TNF-(a) produksjon og hemning av interieukin-1 - (IL-1) produksjon, så vel som deres analgetiske virkning.
NO20044507A 2002-04-10 2004-10-21 1-oksa-3-aza-dibenzoazulener som inhibitorer av tumornekrosefaktorproduksjon og mellomprodukter for fremstilling derav NO20044507L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20020304A HRP20020304B1 (en) 2002-04-10 2002-04-10 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
PCT/HR2003/000015 WO2003084964A1 (en) 2002-04-10 2003-04-09 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof

Publications (1)

Publication Number Publication Date
NO20044507L true NO20044507L (no) 2004-11-09

Family

ID=28686902

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044507A NO20044507L (no) 2002-04-10 2004-10-21 1-oksa-3-aza-dibenzoazulener som inhibitorer av tumornekrosefaktorproduksjon og mellomprodukter for fremstilling derav

Country Status (23)

Country Link
US (1) US7232815B2 (no)
EP (1) EP1492797B1 (no)
JP (1) JP2005529867A (no)
CN (1) CN1649878A (no)
AT (1) ATE320434T1 (no)
AU (1) AU2003259960A1 (no)
BR (1) BR0309101A (no)
CA (1) CA2481463A1 (no)
DE (1) DE60304047T2 (no)
DK (1) DK1492797T3 (no)
ES (1) ES2260636T3 (no)
HR (1) HRP20020304B1 (no)
IL (1) IL164397A0 (no)
IS (1) IS7473A (no)
MX (1) MXPA04009944A (no)
NO (1) NO20044507L (no)
NZ (1) NZ535621A (no)
PL (1) PL372456A1 (no)
PT (1) PT1492797E (no)
RU (1) RU2323222C2 (no)
UA (1) UA79276C2 (no)
WO (1) WO2003084964A1 (no)
YU (1) YU88204A (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
DE10256416A1 (de) * 2002-12-02 2004-06-09 Basf Ag Feste Pigmentzubereitungen, enthaltend Pigmentderivate und oberflächenaktive Additive
HRP20030959A2 (no) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o.
JP2008532927A (ja) * 2005-01-13 2008-08-21 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症マクロライド接合体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745167A (en) * 1968-03-19 1973-07-10 Hoffmann La Roche 3a,12b-dihydro-8h-dibenzo(3,4,6,7)cyclohept(1,2,-)oxazol-8-ones and processes for their preparation
JPS458611Y1 (no) 1969-08-18 1970-04-22
GB1340637A (en) * 1971-02-05 1973-12-12 Richardson Merrell Spa Dibenzocycloheptadioxolan derivatives
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en) 1972-12-22 1975-05-13 Joseph G. Lombardino Tetracyclic anti-inflammatory agents
US4198421A (en) 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
PT789702E (pt) * 1994-11-02 2001-07-31 Janssen Pharmaceutica N V Jans Derivados de oxazepina e tiazepina tetraciclicos substituidos com afinidade para receptores 5-ht2
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020305A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020303A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
US20050131056A1 (en) * 2002-04-10 2005-06-16 Pliva-Istrazivacki Institut D.O.O. 2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020453A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020451A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS

Also Published As

Publication number Publication date
RU2004132867A (ru) 2005-05-10
IS7473A (is) 2004-09-27
US20050148576A1 (en) 2005-07-07
CA2481463A1 (en) 2003-10-16
PL372456A1 (en) 2005-07-25
EP1492797A1 (en) 2005-01-05
DK1492797T3 (da) 2006-07-17
US7232815B2 (en) 2007-06-19
HRP20020304A2 (en) 2004-06-30
AU2003259960A1 (en) 2003-10-20
RU2323222C2 (ru) 2008-04-27
DE60304047D1 (de) 2006-05-11
PT1492797E (pt) 2006-07-31
CN1649878A (zh) 2005-08-03
ES2260636T3 (es) 2006-11-01
MXPA04009944A (es) 2005-09-30
JP2005529867A (ja) 2005-10-06
UA79276C2 (en) 2007-06-11
EP1492797B1 (en) 2006-03-15
ATE320434T1 (de) 2006-04-15
HRP20020304B1 (en) 2008-04-30
WO2003084964A1 (en) 2003-10-16
IL164397A0 (en) 2005-12-18
NZ535621A (en) 2006-03-31
BR0309101A (pt) 2005-02-09
DE60304047T2 (de) 2006-11-09
YU88204A (sh) 2006-08-17

Similar Documents

Publication Publication Date Title
MXPA03006248A (es) Derivados de acido fumarico como inhibidores de nf-kappab.
ATE465146T1 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE377004T1 (de) Proteinkinaseinhibitoren
DE60331187D1 (de) Kinaseinhibitoren
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
NO20062150L (no) Nye ketooksadiazolderivater som katepsinhibitorer
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
NO20044508L (no) 1-eller 3-tia-henzonaftoazulener som inhibitorer av tumornektrosefaktorproduksjon og mellomprodukter for fremstilling derav
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
WO2003097649A3 (en) 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
NO20044506L (no) 2-tia-dibenzoazulener som inhibitorer for tumornekrosefaktorproduksjon og mellomprodukter for fremstilling derav
WO2003099823A3 (en) 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
IL164397A0 (en) 1-Oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates forthe production thereof
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600454A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
UA80905C2 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
EA200600249A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ITTO20050220A1 (it) Nuova utilizzazione terapeutica della molsidomina e dei suoi sali farmaceuticamente accettabili

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application